Zotiraciclib diHCl (TG-02, SB-1317)

Zotiraciclib diHCl (TG-02, SB-1317) Suppliers list
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:Zotiraciclib diHCl (TG-02, SB-1317)
CAS:1354567-82-0
Purity:98% Package:10mg Remarks:V7904
Company Name: InvivoChem  
Tel: 13549236410
Email: sales@invivochem.cn
Products Intro: Product Name:Zotiraciclib diHCl (TG-02, SB-1317)
CAS:1354567-82-0
Purity:98% HPLC Package:1mg Remarks:V7904
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:Zotiraciclib HCl
CAS:1354567-82-0
Purity:详情请点击官网 Package:1 mg
Zotiraciclib diHCl (TG-02, SB-1317) Basic information
Product Name:Zotiraciclib diHCl (TG-02, SB-1317)
Synonyms:Zotiraciclib diHCl (TG-02, SB-1317);Zotiraciclib HCl
CAS:1354567-82-0
MF:C23H25ClN4O
MW:408.93
EINECS:
Product Categories:
Mol File:1354567-82-0.mol
Zotiraciclib diHCl (TG-02, SB-1317) Structure
Zotiraciclib diHCl (TG-02, SB-1317) Chemical Properties
Safety Information
MSDS Information
Zotiraciclib diHCl (TG-02, SB-1317) Usage And Synthesis
DescriptionZotiraciclib, also known as TG02 and SB1317, is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9). It is one of a number of CDK inhibitors under investigation; others targeting CDK9 for the treatment of acute myeloid leukemia include alvocidib and atuveciclib. Myc overexpression is a known factor in many cancers, with 80 percent of glioblastomas characterized by this property.
Zotiraciclib diHCl (TG-02, SB-1317) Preparation Products And Raw materials
Tag:Zotiraciclib diHCl (TG-02, SB-1317)(1354567-82-0) Related Product Information
SB1317 SB1317